Abdominal Aneurysm - ClinicalTrials.gov

Brain and Abdominal Aneurysm Study (BAAS)

Screening has effectively reduced the risk of an aortic aneurysm death before rupture, but a significant number of those who die did not have a diagnosis of aortic aneurysm prior to rupture. Individuals and families living one type of aneurysm may be at an elevated risk of the other, according to these GWAS findings, as well as linkage results for other susceptibility loci. The motivation for this program is that aneurysmal subarachnoid hemorrhage screening for abdominal aortic aneurysms may be helpful in patients with aneurysmal subarachnoid hemorrhage. In all cases of a SAH presenting to MCH for care, the investigators intend to screen for AAA. If no one out of 81 consecutively tested cases of aSAH has evidence of AAA, then the investigators will have a great deal of finding an AAA in the patient population.

Source link: https://clinicaltrials.gov/ct2/show/NCT01420991

Modern Technology For Learning and Psychosocial Support In Patients With Abdominal Aortic Aneurysm

Abdominal aortic anuerysm is linked to a reduced quality of life both at diagnosis and during surgical treatment, although recent studies show somewhat contradictory findings. It has been found that in qualitative research, the health care system fails to satisfy the patients' information demand as well as their desire for psychosocial assistance during the care process. Patients undergoing surgical treatment for AAA are therefore expected to determine the effects of an intervention involving an eHealth device with personalized data in combination with a structured follow-up by a contact nurse on anxiety, depression, and HRQoL in patients undergoing surgical treatment for AAA.

Source link: https://clinicaltrials.gov/ct2/show/NCT03157973

A Controlled, Open-label, 3-arm Parallel Group, Multi-center Study to Evaluate the Abdominal Aortic Aneurysm (AAA) Growth Rate in Adult Smoking Patients Randomized to Either Cigarette Smoking or IQOS Use and to Compare With the AAA Growth Rate in Patients Who Had Stopped Smoking

AAA patients who had entirely quit smoking and using any other nicotine-containing drugs within 2 months of their AAA diagnosis were found to be enrolled in the smoking cessation program without randomization, and are currently impstinent at the time of the Screening Visit and Baseline Visit, and are now abstinent.

Source link: https://clinicaltrials.gov/ct2/show/NCT03837704

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions